BFBIO Pharmaceuticals: Major
Health Technology
Mkt Cap
12.2B
P/E (TTM)
20.68
EPS
5.52
ROE
12.25%
Div Yield
—
About
BF Biosciences Ltd. is a biotech company. The firm is engaged in importing, manufacturing, marketing, and distribution of pharmaceutical products in Pakistan. Its products include biological medicines for treating cancer and hepatitis C. It serves biological and non-biological segments effectively. BF Biosciences was founded on February 24, 2006 and is headquartered in Lahore, Pakistan.
Financial Highlights
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Revenue | 5.84B | 3.66B | 1.81B | 1.52B | 1.75B | |
| Gross Profit | 2.24B | 1.50B | 434.55M | 437.22M | 760.81M | |
| Net Income | 447.15M | 385.41M | 149.05M | 306.98M | 607.99M | |
| EPS | 5.52 | 6.09 | 2.35 | 16.16 | 32.00 | |
| ROE | 12.74% | 17.79% | 7.85% | 18.65% | — | |
| ROA | 6.27% | 6.69% | 2.94% | 8.24% | — | |
| Gross Margin | 38.30% | 40.89% | 24.01% | 28.75% | 43.36% | |
| Net Margin | 7.66% | 10.53% | 8.24% | 20.19% | 34.65% | |
| Current Ratio | 2.36 | 1.17 | 1.13 | 3.21 | 4.19 | |
| DPS | 0.00 | — | — | — | — | |
| Free Cash Flow | -46.94M | 376.39M | -2.20B | -838.13M | -357.38M |